Page last updated: 2024-10-27

fluoxetine and Bone Diseases

fluoxetine has been researched along with Bone Diseases in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Bone Diseases: Diseases of BONES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mortazavi, SH1
Khojasteh, A1
Vaziri, H1
Khoshzaban, A1
Roudsari, MV1
Razavi, SH1

Other Studies

1 other study available for fluoxetine and Bone Diseases

ArticleYear
The effect of fluoxetine on bone regeneration in rat calvarial bone defects.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 108, Issue:1

    Topics: Animals; Bone Density Conservation Agents; Bone Diseases; Bone Matrix; Bone Regeneration; Bone Subst

2009